DIGINEX LTD (DGNX) Fundamental Analysis & Valuation

NASDAQ:DGNX • KYG286871044

Current stock price

0.5255 USD
+0 (+0.67%)
At close:
0.51 USD
-0.02 (-2.95%)
After Hours:

This DGNX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DGNX Profitability Analysis

1.1 Basic Checks

  • DGNX had negative earnings in the past year.
  • DGNX had a negative operating cash flow in the past year.
DGNX Yearly Net Income VS EBIT VS OCF VS FCFDGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • DGNX has a Return On Assets of -73.04%. This is amonst the worse of the industry: DGNX underperforms 88.00% of its industry peers.
  • The Return On Equity of DGNX (-101.26%) is worse than 78.18% of its industry peers.
Industry RankSector Rank
ROA -73.04%
ROE -101.26%
ROIC N/A
ROA(3y)-388.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DGNX Yearly ROA, ROE, ROICDGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DGNX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DGNX Yearly Profit, Operating, Gross MarginsDGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 -200 -400 -600 -800 -1K

6

2. DGNX Health Analysis

2.1 Basic Checks

  • DGNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DGNX has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for DGNX has been reduced compared to a year ago.
DGNX Yearly Shares OutstandingDGNX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
DGNX Yearly Total Debt VS Total AssetsDGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • An Altman-Z score of 9.62 indicates that DGNX is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 9.62, DGNX belongs to the best of the industry, outperforming 92.36% of the companies in the same industry.
  • DGNX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.00, DGNX is in the better half of the industry, outperforming 65.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.62
ROIC/WACCN/A
WACC10.83%
DGNX Yearly LT Debt VS Equity VS FCFDGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 10M -10M -20M

2.3 Liquidity

  • A Current Ratio of 3.56 indicates that DGNX has no problem at all paying its short term obligations.
  • DGNX has a better Current ratio (3.56) than 78.55% of its industry peers.
  • DGNX has a Quick Ratio of 3.56. This indicates that DGNX is financially healthy and has no problem in meeting its short term obligations.
  • DGNX has a Quick ratio of 3.56. This is in the better half of the industry: DGNX outperforms 78.55% of its industry peers.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 3.56
DGNX Yearly Current Assets VS Current LiabilitesDGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 5M 10M

3

3. DGNX Growth Analysis

3.1 Past

  • DGNX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -75.98%.
  • The Revenue has grown by 124.47% in the past year. This is a very strong growth!
  • The Revenue has been growing by 22.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-75.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-373.44%
Revenue 1Y (TTM)124.47%
Revenue growth 3Y22.13%
Revenue growth 5YN/A
Sales Q2Q%292.74%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DGNX Yearly Revenue VS EstimatesDGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 500K 1M 1.5M 2M

0

4. DGNX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DGNX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DGNX Price Earnings VS Forward Price EarningsDGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DGNX Per share dataDGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. DGNX Dividend Analysis

5.1 Amount

  • DGNX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DGNX Fundamentals: All Metrics, Ratios and Statistics

DIGINEX LTD

NASDAQ:DGNX (4/10/2026, 8:17:27 PM)

After market: 0.51 -0.02 (-2.95%)

0.5255

+0 (+0.67%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-09
Earnings (Next)N/A
Inst Owners0.39%
Inst Owner ChangeN/A
Ins Owners2.49%
Ins Owner Change0%
Market Cap110.74M
Revenue(TTM)4.09M
Net Income(TTM)-11.02M
AnalystsN/A
Price TargetN/A
Short Float %2.86%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.1
P/FCF N/A
P/OCF N/A
P/B 10.18
P/tB 10.18
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.02
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.04%
ROE -101.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-388.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.56
Quick Ratio 3.56
Altman-Z 9.62
F-Score5
WACC10.83%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-373.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)124.47%
Revenue growth 3Y22.13%
Revenue growth 5YN/A
Sales Q2Q%292.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.98%
OCF growth 3YN/A
OCF growth 5YN/A

DIGINEX LTD / DGNX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DIGINEX LTD?

ChartMill assigns a fundamental rating of 2 / 10 to DGNX.


What is the valuation status for DGNX stock?

ChartMill assigns a valuation rating of 0 / 10 to DIGINEX LTD (DGNX). This can be considered as Overvalued.


How profitable is DIGINEX LTD (DGNX) stock?

DIGINEX LTD (DGNX) has a profitability rating of 0 / 10.


What is the financial health of DIGINEX LTD (DGNX) stock?

The financial health rating of DIGINEX LTD (DGNX) is 6 / 10.